Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology(2023)

引用 0|浏览8
暂无评分
摘要
Dupilumab demonstrated efficacy during prolonged treatment in patients with uncontrolled, moderate-to-severe asthma with FS.
更多
查看译文
关键词
asthma, dupilumab, fungal sensitization
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要